Pages that link to "Q1129007"
Jump to navigation
Jump to search
The following pages link to angioedema (Q1129007):
Displaying 50 items.
- Laura Antonelli (Q239404) (← links)
- MF DOOM (Q304675) (← links)
- fluoxymesterone (Q410663) (← links)
- omalizumab (Q415392) (← links)
- cyproheptadine (Q417884) (← links)
- hereditary angioedema (Q2096745) (← links)
- acquired C1 esterase inhibitor deficiency (Q4674768) (← links)
- Drug-induced angioedema (Q5308806) (← links)
- Gleich's syndrome (Q5567504) (← links)
- alpha-gal allergy (Q16242785) (← links)
- (R)-carbinoxamine (Q27126632) (← links)
- cyproheptadine hydrochloride (Q27126856) (← links)
- Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system. (Q34232188) (← links)
- Efficacy of Treatment of Non-hereditary Angioedema (Q38965393) (← links)
- epinephrine / lidocaine (Q48566660) (← links)
- Hydrochlorothiazide / Lisinopril (Q48566700) (← links)
- non-histaminic angioedema (Q55788444) (← links)
- Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) (Q61920543) (← links)
- CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12 (Q61936655) (← links)
- A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration (Q61936656) (← links)
- Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert (Q61956095) (← links)
- Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE (Q61965968) (← links)
- Patient Registry Study of Berinert® in Normal Clinical Practice (Q61967878) (← links)
- Dupilumab in Chronic Spontaneous Urticaria (Q62034108) (← links)
- A Safety Study For Prevenar 13 Among Chinese Children (Q62062660) (← links)
- Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE (Q62809446) (← links)
- COrticosteroids in acUte uRticAria in emerGency dEpartment (Q62810272) (← links)
- A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route (Q63315681) (← links)
- Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema (Q63315992) (← links)
- A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase (Q63321050) (← links)
- Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists (Q63335420) (← links)
- Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients (Q63335562) (← links)
- Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema (Q63337006) (← links)
- A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants (Q63581089) (← links)
- Patient Registry to Evaluate the Real-world Safety of Ruconest® (Q63598112) (← links)
- A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE) (Q63599080) (← links)
- C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks (Q63807589) (← links)
- Study to Evaluate the Efficacy and Safety of BCX7353 as an Oral Treatment for the Prevention of HAE Attacks in Japan (Q63808776) (← links)
- Epidemiological Analysis for Hereditary Angioedema Disease (Q63811700) (← links)
- The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment (Q63812989) (← links)
- Biomarker for Hereditary Angioedema Disease Type 1 (Q63813141) (← links)
- Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema (Q63818584) (← links)
- C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) Exacerbation (Q63829418) (← links)
- Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema (Q63835049) (← links)
- Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks (Q63838500) (← links)
- A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor (Q64070555) (← links)
- Screening Protocol for Genetic Diseases of Allergic Inflammation (Q64170898) (← links)
- Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE (Q64171249) (← links)
- Evaluation of New Markers in Type 3 Angioedema (Q64185262) (← links)
- Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects (Q64220417) (← links)